Analyst Consensus ?
ConsensusBuy39 ratings
Bullish2974.4%
Neutral1025.6%
Bearish00.0%
FN2 Earnings Intelligence
Cigna Corporation analyst ratings
Cigna Corporation (CI) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$299.45Current
$225Low
$324.61Average
$415High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Overweight | Overweight | Maintain | Oct 2, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 1, 2026 |
| Jefferies | Hold | Buy | Downgrade | Aug 4, 2026 |
| Raymond James | Outperform | Strong Buy | Downgrade | Aug 3, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 31, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 31, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 31, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 9, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 8, 2026 |
| UBS | Buy | Buy | Maintain | May 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | May 20, 2026 |
| Deutsche Bank | Hold | Buy | Downgrade | May 20, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | May 1, 2026 |
| Truist Securities | Buy | Buy | Maintain | Feb 17, 2026 |
| TD Cowen | Buy | Buy | Maintain | Feb 9, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Nov 4, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 4, 2025 |
| Baird | Outperform | Outperform | Maintain | Aug 14, 2025 |
| Stephens& Co. | Overweight | Overweight | Maintain | Jan 31, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jan 31, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 31, 2025 |
| Edward Jones | Hold | Buy | Downgrade | Aug 18, 2023 |
| B of A Securities | Buy | Buy | Maintain | Aug 4, 2023 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Feb 8, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 7, 2022 |
| Loop Capital | Hold | Hold | Maintain | Jun 17, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | May 9, 2022 |
| Seaport Global | Buy | Buy | Maintain | Nov 17, 2021 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 8, 2021 |
| Citigroup | Buy | Buy | Maintain | Feb 5, 2021 |
| Wedbush | Neutral | Neutral | Maintain | Nov 25, 2020 |
| Susquehanna | Outperform | Neutral | Upgrade | Nov 25, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Nov 25, 2020 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Nov 25, 2020 |
| Sterne Agee | Neutral | Buy | Downgrade | Nov 25, 2020 |
| Monness Crespi Hardt | Buy | Buy | Maintain | Nov 25, 2020 |
| Leerink Swann | Outperform | Outperform | Maintain | Nov 25, 2020 |
| Bank of America | Buy | Buy | Maintain | Nov 25, 2020 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Nov 5, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $299.45. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $387 | $268.88 | +29.2% | Oct 2, 2026 |
| Piper Sandler | Jessica Tassan | $370 | $267.96 | +23.6% | Oct 2, 2026 |
| Jefferies | David Windley | $307 | $282.06 | +2.5% | Aug 4, 2026 |
| Raymond James | Analyst unavailable | $320 | $279.05 | +6.9% | Aug 3, 2026 |
| Robert W. Baird | Analyst unavailable | $362 | $287.66 | +20.9% | Jul 31, 2026 |
| Guggenheim | Analyst unavailable | $361 | $287.66 | +20.6% | Jul 31, 2026 |
| Wells Fargo | Analyst unavailable | $307 | $287.66 | +2.5% | Jul 31, 2026 |
| Bernstein | Analyst unavailable | $381 | $289.73 | +27.2% | Jul 8, 2026 |
| Wolfe Research | Justin Lake | $315 | $293.83 | +5.2% | Jun 16, 2026 |
| Mizuho Securities | Ann Hynes | $340 | $289.48 | +13.5% | Jun 8, 2026 |
| Barclays | Analyst unavailable | $304 | $286.24 | +1.5% | May 26, 2026 |
| UBS | Analyst unavailable | $400 | $282.02 | +33.6% | May 22, 2026 |
| Morgan Stanley | Analyst unavailable | $361 | $291.28 | +20.6% | May 20, 2026 |
| Deutsche Bank | Analyst unavailable | $302 | $291.28 | +0.9% | May 20, 2026 |
| Bernstein | Analyst unavailable | $371 | $279.35 | +23.9% | May 5, 2026 |
| Raymond James | Sarah James | $340 | $285.11 | +13.5% | May 1, 2026 |
| Robert W. Baird | Analyst unavailable | $337 | $285.6 | +12.5% | May 1, 2026 |
| Mizuho Securities | Analyst unavailable | $330 | $285.54 | +10.2% | May 1, 2026 |
| Barclays | Analyst unavailable | $310 | $290.58 | +3.5% | May 1, 2026 |
| Jefferies | Analyst unavailable | $330 | $278.64 | +10.2% | Apr 20, 2026 |
| Truist Financial | Analyst unavailable | $350 | $292.76 | +16.9% | Feb 17, 2026 |
| Deutsche Bank | Analyst unavailable | $304 | $291.17 | +1.5% | Feb 10, 2026 |
| Truist Financial | Analyst unavailable | $338 | $294.2 | +12.9% | Feb 9, 2026 |
| UBS | Analyst unavailable | $375 | $292.84 | +25.2% | Feb 9, 2026 |
| Barclays | Andrew Mok | $303 | $284.53 | +1.2% | Feb 6, 2026 |
| Mizuho Securities | Analyst unavailable | $325 | $283.91 | +8.5% | Jan 9, 2026 |
| Bernstein | Analyst unavailable | $307 | $287.1 | +2.5% | Jan 6, 2026 |
| Truist Financial | Analyst unavailable | $320 | $279.12 | +6.9% | Jan 5, 2026 |
| Barclays | Analyst unavailable | $305 | $279.12 | +1.9% | Jan 5, 2026 |
| Cowen & Co. | Charles Rhyee | $333 | $274.87 | +11.2% | Dec 15, 2025 |
| Guggenheim | Analyst unavailable | $318 | $273.57 | +6.2% | Dec 2, 2025 |
| Bernstein | Analyst unavailable | $294 | $271.57 | -1.8% | Nov 12, 2025 |
| UBS | Analyst unavailable | $294 | $268 | -1.8% | Nov 12, 2025 |
| Wells Fargo | Analyst unavailable | $300 | $264.66 | +0.2% | Nov 5, 2025 |
| Goldman Sachs | Scott Fidel | $330 | $258.62 | +10.2% | Nov 4, 2025 |
| Jefferies | David Windley | $310 | $244.41 | +3.5% | Nov 3, 2025 |
| Morgan Stanley | Erin Wright | $355 | $243 | +18.6% | Oct 31, 2025 |
| Barclays | Analyst unavailable | $300 | $245.1 | +0.2% | Oct 31, 2025 |
| Goldman Sachs | Scott Fidel | $370 | $295.41 | +23.6% | Oct 14, 2025 |
| Wells Fargo | Analyst unavailable | $354 | $302.99 | +18.2% | Oct 7, 2025 |
| Truist Financial | David MacDonald | $375 | $300.72 | +25.2% | Sep 2, 2025 |
| Robert W. Baird | Michael Ha | $372 | $286 | +24.2% | Aug 14, 2025 |
| Deutsche Bank | George Hill | $415 | $270.74 | +38.6% | Aug 5, 2025 |
| Guggenheim | Jason Cassorla | $388 | $333.82 | +29.6% | May 6, 2025 |
| Morgan Stanley | Erin Wright | $390 | $333.01 | +30.2% | May 5, 2025 |
| Barclays | Andrew Mok | $382 | $333.01 | +27.6% | May 5, 2025 |
| Wells Fargo | Stephen Baxter | $341 | $291.46 | +13.9% | Feb 4, 2025 |
| Piper Sandler | Jessica Tassan | $348 | $292.46 | +16.2% | Feb 3, 2025 |
| Raymond James | John Ransom | $360 | $294.21 | +20.2% | Jan 31, 2025 |
| Morgan Stanley | Erin Wright | $379 | $294.21 | +26.6% | Jan 31, 2025 |
| RBC Capital | Ben Hendrix | $355 | $294.21 | +18.6% | Jan 31, 2025 |
| Piper Sandler | Jessica Tassan | $400 | $338.8 | +33.6% | Jun 25, 2024 |
| Robert W. Baird | Michael Ha | $388 | $332.92 | +29.6% | May 29, 2024 |
| Jefferies | David Windley | $407 | $341.5 | +35.9% | May 6, 2024 |
| Oppenheimer | Michael Wiederhorn | $400 | $344.5 | +33.6% | May 3, 2024 |
| Raymond James | Sarah James | $400 | $344.5 | +33.6% | May 3, 2024 |
| RBC Capital | Ben Hendrix | $384 | $344.5 | +28.2% | May 3, 2024 |
| RBC Capital | Ben Hendrix | $354 | $324.06 | +18.2% | Feb 5, 2024 |
| Deutsche Bank | George Hill | $370 | $307.32 | +23.6% | Feb 1, 2024 |
| Leerink Partners | Analyst unavailable | $335 | $289 | +11.9% | Feb 8, 2023 |
| Raymond James | Analyst unavailable | $350 | $288.44 | +16.9% | Feb 7, 2023 |
| Stephens | Analyst unavailable | $370 | $289.12 | +23.6% | Feb 6, 2023 |
| Morgan Stanley | Analyst unavailable | $365 | $301.95 | +21.9% | Jan 6, 2023 |
| Morgan Stanley | Analyst unavailable | $347 | $320.9 | +15.9% | Nov 23, 2022 |
| Raymond James | John Ransom | $370 | $322.13 | +23.6% | Nov 6, 2022 |
| Truist Financial | David MacDonald | $330 | $272.63 | +10.2% | Jul 26, 2022 |
| Jefferies | David Windley | $271 | $273.75 | -9.5% | Jul 14, 2022 |
| Morgan Stanley | Ricky Goldwasser | $296 | $257.6 | -1.2% | Jun 22, 2022 |
| Deutsche Bank | George Hill | $284 | $244.52 | -5.2% | Jun 18, 2022 |
| Mizuho Securities | Ann Hynes | $291 | $263.98 | -2.8% | May 9, 2022 |
| Stephens | Analyst unavailable | $290 | $265.6 | -3.2% | Apr 20, 2022 |
| Truist Financial | David MacDonald | $290 | $254.12 | -3.2% | Apr 11, 2022 |
| Mizuho Securities | Ann Hynes | $266 | $240.51 | -11.2% | Mar 2, 2022 |
| Wells Fargo | Steve Baxter | $278 | $226.47 | -7.2% | Jan 6, 2022 |
| J.P. Morgan | Lisa Gill | $248 | $219.2 | -17.2% | Dec 21, 2021 |
| Goldman Sachs | Nathan Rich | $233 | $215.6 | -22.2% | Dec 14, 2021 |
| UBS | Kevin Caliendo | $244 | $216.63 | -18.5% | Nov 18, 2021 |
| Credit Suisse | A.J. Rice | $300 | $216.05 | +0.2% | Nov 8, 2021 |
| Evercore ISI | Michael Newshel | $230 | $211.09 | -23.2% | Nov 4, 2021 |
| Bank of America Securities | Kevin Fischbeck | $225 | $202.71 | -24.9% | Sep 10, 2021 |
| Cowen & Co. | Gary Taylor | $235 | $211.88 | -21.5% | Sep 9, 2021 |
| Raymond James | John Ransom | $275 | $208.14 | -8.2% | Aug 9, 2021 |
| Stephens | Scott Fidel | $270 | $206.32 | -9.8% | Aug 6, 2021 |
| Barclays | Steven Valiquette | $275 | $206.32 | -8.2% | Aug 6, 2021 |
| Oppenheimer | Michael Wiederhorn | $285 | $206.32 | -4.8% | Aug 6, 2021 |
| Cantor Fitzgerald | Steven Halper | $250 | $203.27 | -16.5% | Aug 5, 2021 |
| Wolfe Research | Justin Lake | $294 | $244.85 | -1.8% | Apr 26, 2021 |
Track every rating change on CI the moment it posts. Free to start.
Start freeGet the CI recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.